Breaking News, Collaborations & Alliances

Pharma Nobis Acquires Fagron’s Contract Manufacturing Business

Names Todd Daviau CEO.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

An investment consortium led by Signet Healthcare Partners, Bionpharma and GMS Capital Partners has formed Pharma Nobis to acquire Fagron’s U.S. contract manufacturing business. This business unit, operating from a manufacturing facility in Texarkana, TX, provides contract manufacturing and private label services for consumer healthcare companies and retailers in the U.S. Fagron will retain a 20% interest in the company. Todd Daviau, co-founder and former president and CEO of CoreRx, a pharmaceu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters